AMHERST, Mass. (WWLP) – A University of Massachusetts Amherst research team has been awarded up to $3.45 million from the National Institutes of Health to help develop a new way to prevent the ...
The PD-1 and PD-L1 inhibitors competitive landscape report delivers important insights into approved as well as ongoing research of 200+ pipeline PD-1 and PD-L1 inhibitor drugs, clinical strategies, ...
Genomics says it is on track to build out a CLIA-certified laboratory set to open next year, part of the spatial and ...
Keytruda is expected to drive another strong quarter for MRK, with investors watching Q2 sales and management's outlook ahead ...
A young boy born a world away finds hope in a forever family in Bay Village and beats a cancer that could have been fatal.
Newsable Asianet News on MSN
Why Did CVS, URGN, CCK Stocks Hit 52-Week Highs Today?
Investors showed confidence in healthcare improvements, strong biotech patents, and rising packaging demand.
A Southland cancer patient who needs regular surgery to control the growth has faced weeks of delays after a cancellation.
A major breakthrough in oncology promises to transform the medical landscape for thousands of patients. Pharmaceutical giant ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
Strong India growth and M&A are expected to drive June-quarter revenues, but fading Revlimid sales, US pricing pressure and ...
Junshi Biosciences Announces Acceptance Of The Supplemental Application For Toripalimab Plus Chemotherapy As Perioperative Treatment For Resectable Stage II-III NSCLC. SHANGHAI, July 21, 2026 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results